49 Wealth Management’s Boston Scientific BSX Stock Holding History

49 Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,404	Closed	-$229K	–	211
2025 Q4	$229K	Hold	2,404	–	–	0.02%	176
2025 Q3	$235K	Sell	2,404 -12	-0.5%	-$1.24K	0.02%	169
2025 Q2	$260K	Sell	2,416 -21	-0.9%	-$2.13K	0.03%	145
2025 Q1	$246K	Hold	2,437	–	–	0.03%	154
2024 Q4	$218K	Sell	2,437 -51	-2%	-$4.49K	0.03%	150
2024 Q3	$208K	Buy	+2,488	New	+$196K	0.03%	157

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

49 Wealth Management's BSX Position: Q1 2026 in Review

49 Wealth Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,404 shares — an estimated $229K sold.

49 Wealth Management first reported a position in BSX in Q3 2024 and held it in 6 quarters. The position peaked at $260K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

49 Wealth Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
49 Wealth Management sold 2,404 Boston Scientific shares in Q1 2026, an estimated $229K.
49 Wealth Management first reported a position in Boston Scientific in Q3 2024 and held it in 6 quarters.
49 Wealth Management's Boston Scientific position peaked at $260K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on 49 Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.